Fractionated stereotactic radiotherapy of vestibular schwannomas accelerates hearing loss

Rune Rasmussen, Magnus Claesson, Sven-Eric Stangerup, Henrik Roed, Ib Jarle Christensen, Per Caye Thomasen, Marianne Juhler

    Research output: Contribution to journalJournal articleResearchpeer-review

    37 Citations (Scopus)

    Abstract

    To evaluate long-term tumor control and hearing preservation rates in patients with vestibular schwannoma treated with fractionated stereotactic radiotherapy (FSRT), comparing hearing preservation rates to an untreated control group. The relationship between radiation dose to the cochlea and hearing preservation was also investigated.
    Original languageEnglish
    JournalInternational Journal of Radiation Oncology, Biology, Physics
    Volume83
    Issue number5
    Pages (from-to)e607-11
    ISSN0360-3016
    DOIs
    Publication statusPublished - 2012

    Cite this